Marissa Shapiro

MBP091, an investigational, anti-Marburg virus antibody identified by Vanderbilt Health researchers and under development by San Diego-based Mapp Biopharmaceutical Inc., was provided to Ethiopian health officials during that country’s first outbreak of the deadly viral infection late last year. Read More

Katrin Karbstein, the co-leader of the Cancer Cell Biology Research Program in the Vanderbilt-Ingram Cancer Center, will now expand her focus to support her department’s mission across research, service, and education, with a special focus on faculty affairs. Read More

New study from Borden Lacy and Audrey Thomas represents a major step forward for vaccine development for C. diff, the leading cause of health care- and antibiotic-associated infection. Read More

Shan Meltzer was named a Sloan Research Fellow, one of the most competitive honors available to young investigators, for her research into how the neural circuits responsible for touch and pain processing are built and organized. Read More

Ann Richmond outlines a promising therapeutic strategy that may re-sensitize treatment-resistant tumors to immunotherapy. The research introduces a three-drug combination that enhances immune activity and suppresses tumor-promoting immune cells. Read More

In a new study, Vanderbilt researchers found that by promoting the formation of actin cytoskeleton inside the epithelial cells lining the proximal tubules, Rac1 facilitates removal and replacement of mitochondria damaged by ischemia. Read More

“After this trip, I now see the job search, networking, and application process as an exciting journey—a journey to meet great people, to better understand myself, to identify work cultures where I can belong and thrive, and to develop professional skills beyond my Ph.D. training,” Zhengyi Chen, a Ph.D. candidate in chemical and physical biology said. Read More

With novel insights in understanding and treating substance use disorder that have redirected neuropsychopharmacological dogma, Erin Calipari receives award from the American College of Neuropsychopharmacology. Read More

Niswender’s project seeks to understand why levels of mGlu7 are reduced in Rett syndrome and to test a new therapeutic approach using DNA molecules to restore those levels. This work could pave the way for new drug therapies to address symptoms of Rett syndrome and related disorders, while also advancing advocacy and visibility for these conditions in the scientific community. Read More

They are among 6,868 scientists worldwide whose papers rank in the top 1% by citations for their fields of research and publication year in the Web of Science Core Collection over the past 11 years. Read More